Description:

NCT00565851 GYNECOLOGIC ONCOLOGY GROUP Solid Tumor Evaluation Form - FORM D2M Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DA2BF104-B72B-1DC3-E034-0003BA12F5E7

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DA2BF104-B72B-1DC3-E034-0003BA12F5E7

Keywords:
Versions (3) ▾
  1. 9/19/12
  2. 1/9/15
  3. 6/26/15
Uploaded on:

June 26, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

NCT00565851 GYNECOLOGIC ONCOLOGY GROUP Solid Tumor Evaluation Form - FORM D2M

No Instruction available.

  1. StudyEvent: GYNECOLOGIC ONCOLOGY GROUP Solid Tumor Evaluation Form - FORM D2M
    1. No Instruction available.
Patient demographics
Target Lesion(s) Evaluation
cm
Non-target Lesion(s) Evaluation
Are there any nontarget lesions? (If no, skip to the New Lesions section below.)
Follow-up status of lesion (s^)
New Target Lesion(s) At Follow-up Evaluation
Was the appearance of any new lesions documented since the baseline evaluation? (If no, skip the Overall Response section below.)
Overall Response
Overall response status at this assessment (check one)
Comments

Similar models